GLP-1 Receptor Agonist Market Estimated To Witness High Growth...

adicionou um novo artigo Outro

2023-12-14 12:42:37 -

GLP-1 Receptor Agonist Market Estimated To Witness High Growth Owing To Increased Prevalence of Diabetes

The GLP-1 Receptor Agonist market is estimated to be valued at US$ 14319.85 Mn in 2023 and is expected to exhibit a CAGR of 6.1% over the forecast period 2023 to 2030, as highlighted in a new report published by Coherent Market Insights. GLP-1 receptor agonists are injectable drugs used for the treatment of type 2 diabetes. They work by increasing insulin secretion, decreasing glucagon...

0 Comentários 0 Compartilhamentos 816 Visualizações 0 Anterior